Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1166]
News [2570]
Articles [163]
Editorials [8]
Conferences [105]
elearning [18]
KEYNOTE-426: Pembrolizumab and axitinib vs sunitinib in advanced renal cell...
Prof Brian Rini - Cleveland Clinic, Cleveland, USA
KEYNOTE-426: Pembrolizumab and axitinib vs sunitinib in advanced renal cell carcinoma ( Prof Brian Rini - Cleveland Clinic, Cleveland, USA )
14 Feb 2019
ASCO GU 2019 renal highlights
Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
ASCO GU 2019 renal highlights ( Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )
14 Feb 2019
ARCHES trial: Androgen deprivation therapy with enzalutamide or placebo in mHSPC
Prof Andrew Armstrong - Duke Cancer Institute, Durham, USA
ARCHES trial: Androgen deprivation therapy with enzalutamide or placebo in mHSPC ( Prof Andrew Armstrong - Duke Cancer Institute, Durham, USA )
14 Feb 2019
Latest from Tivo-3: Tivozanib for refractory advanced renal cell carcinoma
Prof Brian Rini - Cleveland Clinic, Cleveland, USA
Latest from Tivo-3: Tivozanib for refractory advanced renal cell carcinoma ( Prof Brian Rini - Cleveland Clinic, Cleveland, USA )
14 Feb 2019
Sacituzumab govitecan in patients with previously treated metastatic urothelial...
Dr Scott Tagawa - Weill Cornell Medicine, New York City, USA
Sacituzumab govitecan in patients with previously treated metastatic urothelial cancer ( Dr Scott Tagawa - Weill Cornell Medicine, New York City, USA )
14 Feb 2019
Whole genome and transcriptome analysis of metastatic adrenocortical carcinoma
Dr Jean-Michel Lavoie - BC Cancer, Vancouver, Canada
Whole genome and transcriptome analysis of metastatic adrenocortical carcinoma ( Dr Jean-Michel Lavoie - BC Cancer, Vancouver, Canada )
14 Feb 2019
Updates from KEYNOTE 57: Pembrolizumab for patients with bladder cancer
Dr Arjun Balar - NYU Langone Health, New York City, USA
Updates from KEYNOTE 57: Pembrolizumab for patients with bladder cancer ( Dr Arjun Balar - NYU Langone Health, New York City, USA )
14 Feb 2019
CHEIRON study: Docetaxel plus enzalutamide versus docetaxel as first-line...
Dr Orazio Caffo - Santa Chiara Hospital, Trento, Italy
CHEIRON study: Docetaxel plus enzalutamide versus docetaxel as first-line chemotherapy for patients with mCRPC ( Dr Orazio Caffo - Santa Chiara Hospital, Trento, Italy )
14 Feb 2019
Treating metastatic prostate cancer in geriatric patients
Dr Shabbir Alibhai - Princess Margaret Cancer Center, Toronto, Canada
Treating metastatic prostate cancer in geriatric patients ( Dr Shabbir Alibhai - Princess Margaret Cancer Center, Toronto, Canada )
23 Nov 2018
Improving the management of senior adults with prostate cancer
Prof Amit Bahl, Prof Nicolas Mottet, Prof Jean-Pierre Droz and Henriette Breunis
Improving the management of senior adults with prostate cancer ( Prof Amit Bahl, Prof Nicolas Mottet, Prof Jean-Pierre Droz and Henriette Breunis )
21 Nov 2018
TRITON2: Evaluation of rucaparib in patients with metastatic castration...
Dr Josep Piulats - IDIBELL, Barcelona, Spain
TRITON2: Evaluation of rucaparib in patients with metastatic castration-resistant prostate cancer ( Dr Josep Piulats - IDIBELL, Barcelona, Spain )
26 Oct 2018
IMpower132: atezolizumab, carboplatin and pemetrexed as first line treatment in...
Dr Fabrice Barlesi - Aix-Marseille University, Marseille, France
IMpower132: atezolizumab, carboplatin and pemetrexed as first line treatment in key subgroups with stage IV non-squamous NSCLC ( Dr Fabrice Barlesi - Aix-Marseille University, Marseille, France )
25 Oct 2018

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation